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Bacopa monnieri (L), belonging to the Scrophulariaceae family and commonly known as Brahmi, is well 
known in India for its CNS activity but its neuropharmacological effect has not yet been explored. In the 
present study, the antiepileptic effects of the plant were investigated. The ethanolic extract of Bacopa 
monniera was tested for anticonvulsant activity in albino rats, using different convulsive models. The 
ethanolic extract of leaves produced significant anticonvulsant activity for all the different models studied. 
The present study shows a probable mechanism of action similar to that of benzodiazepines (GABA 
agonist). Thus, these results emphasize the need to diversify by using alternative therapeutic approaches 
pertaining to herbal medicine, where a single easily available plant may provide solutions to several 
therapeutic challenges, as observed in the anticonvulsant action of ethanolic extract of B. monniera.
Uniterms: Bacopa monniera/pharmacognosy. Anticonvulsant. MES test. PTZ model. Hypoxia model. 
Strychnine model.
Bacopa monniera, da família Scrophulariaceae, e comumente denominada Brahmi, é bem conhecida na 
Índia por sua atividade no Sistema Nervoso Central, mas seu efeito neurofarmacológico não foi, ainda, 
explorado. No presente estudo, investigaram-se os efeitos antiepilépticos da planta. O extrato etanólico 
da Bacopa monniera foi testado quanto à atividade anticonvulsivante em ratos albinos, utilizando-se 
diferentes modelos de convulsão. O extrato etanólico das folhas produziu atividade anticonvulsivante 
significativa para todos os diferentes modelos estudados. O presente estudo mostra provável mecanismo de 
ação semelhante ao dos benzodiazepínicos (agonista do GABA). Assim sendo, esses resultados enfatizam 
a necessidade de diversificar, utilizando-se abordagens terapêuticas alternativas da medicina natural, em 
que uma planta facilmente disponível pode fornecer soluções para vários desafios terapêuticos, como o 
observado na ação anticonvulsivante do extrato etanólico de Bacopa monniera.
Unitermos: Bacopa monniera/farmacognosia. Anticonvulsivante. Teste MES. Modelo PTZ. Modelo 
hipóxia. Modelo estricnina.
INTRODUCTION
Bacopa monniera (Scrophulariaceae) is a small, cre-
eping perennial herb, common in marshy places throughout 
India, and found up to an altitude of 1320 m. The drug is 
present throughout the entire dried plant, but principally 
concentrated in leaves and stems (Handa et al., 1998). It 
has a wide range of CNS activity, but is most popularly 
considered a memory enhancer. Other pharmacological 
properties of the extracts include sedation (Kirtikar, Basu, 
1999), cardiotonic (Kirtikar, Basu, 1999), vasoconstriction 
(Handa et al., 1998), anti-inflammatory activity (Viji, He-
len, 2008) and astringency (Wealth of India, 1985). Juice 
of the leaves relieves bronchitis and diarrhea (Wealth of 
India, 1985). A paste of the leaves is used as a remedy for 
rheumatism (Wealth of India, 1985). The entire plant is 
used in indigenous medicine as a nervous tonic (Chopra 
et al., 1956). Brahmighritha, a medicated ghee prepared 
from Bacopa monniera, is beneficial in cases of epilepsy 
and hysteria (Singh, Dhawan, 1997). Hersaponin, one of 
its active compounds, is reported to have a sedative effect 
(Malhotra, Das, 1959). It is also has laxative, carminative, 
digestive, purgative, emmenagogue, sudorific and anti-
pyretic properties. It is useful in treating neuralgia, insanity, 
amentia, cancer, ulcers (Rao, Agarwal, 2000), dyspepsia, 
flatulence, asthma, skin diseases, leucoderma, syphilis, 
hoarseness, dysmenorrhea and sterility (Wealth of India, 
1985). Additionally, it shows cardioprotective (Nandave et 
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al., 2007) and hepatoprotective (Sumathi, Nongbri, 2008) 
effects. The plant is an aphrodisiac, effective in treating 
scabies and syphilis, and purifies the blood, having proven 
useful for diarrheas and pyresis (Kirtikar, Basu, 1999). The 
powdered dried leaf yielded satisfactory results in clinically 
tested cases of asthma, nervous breakdown and other low 
dynamic conditions (Singh, Dhawan, 1997). Bacopa mon-
niera plant is known as a memory enhancer and act toward 
improving intellect (Handa, 1994). Although the plant is 
widely used for several ailments related to the central ner-
vous system, its potential is unexplored. The present study 
was undertaken to investigate the anticonvulsant activity of 
an alcoholic extract of whole Bacopa monniera (BM), in 
different models of convulsion.
MATERIAL AND METHODS
Plant materials
The plant was collected in December 2000 from the 
outlying areas of Kolkatta City, West Bengal, India, and 
identified by staff of the KLE’s RLS Institute, Dept. of 
Botany, Belgaum, Karnataka. The fresh leaves collected 
were shade dried and powdered.
Preparation of Plant Extract
Shade dried, powdered leaves were pounded until 
able to pass through sieve # 20, with 60% v/v ethanol as 
solvent (Chaudhri, 1985). A total of 330 grams of dried 
leaves were soaked for 24 hours, whereupon upon the so-
aking solution was changed for three cycles of maceration. 
The percolate was concentrated in vacuum at < 50 ºC to 
give a semisolid extract (Sertia et al., 1997).
Animals
Wistar albino mice (18-25 g) and Wistar rats 
(150-200 g) of both sexes, purchased from the experi-
mental animal house, Dept. of Livestock Production and 
Management, Veterinary College, Bangalore, were used. 
They were initially acclimatized to the laboratory envi-
ronment for seven days prior to use. Institutional ethical 
committee approval of the experimental animal protocol 
was given for the present study.
Drug Administration
Bacopa monniera (50 mg/kg and 55 mg/kg p.o. for 
rats and mice, respectively) was administered 2 and 4 
hours before the respective convulsive stimuli. Diazepam 
4 mg/kg, i.p (Ranbaxy, India), phenobarbitone 20 mg/kg, 
i.p (Samarath Pharma ltd., India), adenosine 50 mg/kg, 
i.p (Loba Chem., India) and theophylline 50 mg/kg, i.p 
(SOL Pharma, India) were administered 45 minutes be-
fore the respective convulsive stimuli either alone or in 
combination with other drugs. Lithium chloride 3 meq/kg, 
i.p (Loba Chem ltd., India) was administered 21 hours 
before pilocarpine 30 mg/kg, sc (FDC, India) challenge. 
All drugs/chemicals used were dissolved in distilled water.
METHODS
Motor Activity (Kulkarni, 1993)
The mice were divided into two groups of six mice 
each. Mice were first individually placed in the photoacto-
meter and normal movement recorded. After five minutes, 
the counter was stopped and the reading noted. The animal 
was then removed and the counter reset to zero. The same 
procedure was repeated for all animals.
Group 1 received 50 mg/kg BW of extract orally. 
The animals were then individually placed in the photo-
actometer at 0.5, 1, 2, 3, 4, and 5 hours and the readings 
were noted. The results were tabulated and converted into 
percentages for convenient calculations.
Pentylenetetrazol-Induced Convulsions in Rats 
(Gupta et al., 1999) 
Albino rats of 150-200 g body weight were divided 
into five groups of six animals each. The first group, re-
ceiving saline orally, served as control whereas the second 
group received 4mg/kg of diazepam intraperitoneally (ip); 
the third group received a sub protective dose of diazepam, 
i.e. 0.5 mg/kg i.p.; the fourth received 50 mg/kg of BM 
(po); and the fifth group received a sub protective dose of 
diazepam, i.e. 0.5 mg/kg and 50 mg/kg of BM. After an 
hour, all the animals were injected with 80 mg/kg pen-
tylenetetrazol (Sigma, St. Louis, USA) intraperitoneally 
and presence or absence of clonic convulsions was noted 
for each animal.
The % latencies of clonic convulsions were noted, 
and numerically transformed to a seizure score (S) calcu-
lated from the formula:
S = 1- (control Latency/ drug seizure Latency)
In the case of control animal; S = 0, whereas for ani-
mals that did not experience seizures latencies of infinity, 
S =1. This numerical transformation enabled inclusion 
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of all animals in the statistical analysis, irrespective of 
whether they had a seizure or not. The mortality in the 
24h following PTZ, in the different pretreatment groups 
was also recorded. 
Maximal Electroshock (MES) - Induced Convulsion 
in Rats (Rana et al., 1990)
Albino rats of 150-200 g body weight were divided 
into three groups of six animals each. The first group, whi-
ch received saline orally, served as the control whilst the 
second group received 30 mg/kg of phenobarbitone sodium 
intraperitoneal (ip), and third group received 50 mg/kg 
of BM (po). After an hour of treatment, convulsions were 
produced in rats using an “Inco” convulsiometer by deli-
vering current of 150 mA through corneal electrodes for 
a period of 0.2 seconds. The severity of convulsions was 
assessed by the duration of flexion, extension, clonus, 
stupor and recovery phase for each animal. Inhibition of 
extensor phase was studied in this model. 
Strychnine-Induced Convulsion in Rats (Kulkarni, 
Pasty, 1998)
Eighteen albino rats each weighing 150-200 g were 
divided into three groups of six rats each. The first group 
received saline orally and served as the control, while 
the second received 4 mg/kg of diazepam (ip), and third 
group received 50 mg/kg of BM orally. After an hour of 
treatment, 4 mg/kg of strychnine (CDH, Bombay) was 
administered intra peritoneally to control and drug treated 
animals, which produced powerful opisthotonus tonic con-
vulsions of the body and limbs. The latency of convulsions 
and the % mortality was assessed for each animal.
Hypoxic Stress-Induced Convulsions in Mice 
(Kulkarni, Pasty, 1998)
The albino mice each weighing 18-25 g, were divi-
ded into seven groups of six mice each. Group one was 
given saline orally and served as the control; group two 
received 4 mg/kg of diazepam (ip), group three received 
50 mg/kg BM orally, group four received 50 mg/kg ade-
nosine (ip), group five received 50 mg/kg of theophylline 
(ip), group six received 50 mg/kg of BM orally followed 
by 50 mg/kg of adenosine (ip), and group seven received 
50 mg/kg of BM orally followed by 50 mg/kg of theo-
phylline (ip). The mice were put individually into a glass 
container of 370 mL capacity for induction of convulsion. 
The container was air tight, so under these circumstances, 
the animal showed convulsions and then mortality due 
to hypoxia. The latency for convulsions and death was 
assessed for each animal.
Lithium–Pilocarpine-Induced Status Epilepticus 
(Kulkarni et al., 1998)
Eighteen albino rats each weighing between 
150-200 g were divided into three groups of six rats each. 
The first control group received saline orally; the second 
group received 4 mg/kg of diazepam (ip), and third group 
received 50 mg/kg of BM orally. Status epilepticus was 
induced by intra peritoneal injection of 3 meq/kg, (ip) 
lithium chloride, followed by 30 mg/kg, (sc) pilocarpi-
ne 21 h later. The animals were observed for a period 
90 minutes for behavioral seizures. Immobility, repetitive 
chewing, head nodding, vibrissial twitching, forelimb 
clonus with or without rearing and falling, characterized 
behavioral seizures evoked by LiCl/pilocarpine. Seizure 
terminations were defined as the absence of forelimb 
clonus or falling, facial twitching and stop and stare acti-
vity. The onset was taken as the time of onset of forelimb 
clonus with rearing (FC+R). The extract was administered 
2 hours prior to pilocarpine challenge, while diazepam was 
administered 30 minutes prior to pilocarpine challenge.
Statistical Analysis and Calculations
The % inhibition (or decrement) was calculated by 
using the formula:
% inhibition = (1-test reading/ Control reading) x 100
Student’s t- test was performed for statistical analysis.
P<0.05 was considered statistically significant.
RESULT AND DISCUSSION
BM extract showed a broad spectrum of anticon-
vulsant profile against chemical, electrical and hypoxic 
convulsions.
Motor Activity
The dose of BM i.e. 50 mg/kg BW po, produced 
a decrease in loco motor activity starting 30 minutes 
after administration and lasting until the 5th hour. The 
peak decrease in motor activity was seen at the 5th hour 
(20.90%±3.17), compared to the baseline reading at 0 hour 
(Table I). Bacopa monniera elicited its peak CNS depres-
sant activity at the 5th hour in mice. This also indicated the 
election of the 5th hour, after administration of the extract, 
as the time to induce convulsions in mice. 
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Effect on Pentylenetetrazol-Induced Convulsions
Diazepam at 4 mg/kg BW i.p protected the animals 
from PTZ-induced convulsions with no clonic convulsions 
occurring within the period of observation. However, 
at a sub- protective dose of 0.5 mg/kg BW i.p, clonic 
convulsions occurred giving rise to a mean score (S) of 
0.60±0.01. BM at 50 mg/kg orally, gave 40% protection 
with a mean score for PTZ-induced convulsions of S= 
0.40± 0.01 (Table II). Combinations of the sub-protective 
dose of diazepam, 0.5 mg/kg i.p. and BM 50 mg/kg BW. 
po fully protected the animals from clonic convulsions 
with 0% mortality. 
The probable protection in this model (Rho & Ra-
man, 1999) is mediated either by: 
1) Suppression of Ca 2+ conductance across low 
threshold T- type Channels, or
2) Enhancement of GABA
A
 receptor mediated Cl- con-
ductance.
BM can lower the dose of diazepam that is requi-
red for protection against seizures. This may indicate a 
GABAergic mechanism as the effect of diazepam was 
potentiated and similar to a full protective dose of diaze-
pam (4 mg/kg BW, ip). This model reveals that BM may 
be clinically effective against generalized-spike-wave 
absence epilepsies (Rho, Raman, 1999).
Effect on Maximal Electro-shock-Induced 
Convulsion
BM at 50 mg/kg BW po produced a more significant 
effect (P<0.001) in the phases of extension, 5.63 ± 0.49 
minute and recovery 43.56± 2.37(P<0.01) compared to con-
trols 9.0±0.48 and 72.16± 4.37 minutes, respectively (Table 
III). The dose of BM did not stop hind limb extension, but 
decreased it by nearly half the extension time in controls. 
This indicates its ability to prevent the spread of seizure in 
the central nervous system (Rho, Raman, 1999).
The MES model has served to identify antiepileptic 
drugs that are functionally similar to phenytoin and most 
of these compounds display, the same ability to inacti-
vate voltage dependent Na+ channels in a use dependent 
fashion. Such compounds have been shown to suppress 
sustained repetitive firing in cultured neurons (Rho, Ra-
man, 1999).
Thus, BM is expected to have a similar type of 
mechanism, and may be effective against partial and se-
condary generalized seizures.
Effect on Strychnine-Induced Convulsion
BM at 50 mg/kg BW po caused a significant 
TABLE I - Assessment of loco motor activity using a photoactometer
Group Treatment 
(mg/kg)
Percentage decrease of locomotor activity
30 min 1 hr 2 hr 3 hr 4 hr 5 hr
1 BM(50) 65.40±1.48 81.04±1.82 63.74±4.51 36.70±2.68 34.83±2.58 20.90± 3.17
TABLE II - Pentylenetetrazole-Induced convulsions in rats
Treatment (mg/kg)
Mean score 
(Mean ± SEM)
% Mortality
Control 0 ± 0.00 100
Diazepam(4) 1 ± 0.00 **** 0
Diazepam (0.5) 0.60 ± 0.01**** 0
BM (50) 0.40 ± 0.01** 83.33
BM (50) + Diazepam (0.5) 0.63 ± 0.01** 0
N= 6, ** p<0.02, **** p<0.001 (compared to control)
TABLE III - Maximal Electroshock-Induced convulsions in rats
Treatment
(mg/kg)
Time (sec) in various phases of convulsions
Flexion Extension Clonus Stupor Recovery
Control 1.46 ± 0.18 9.0 ± 0.48 9.68 ± 0.57 52.01 ± 4.00 72.16 ± 4.37
Phenobarbitone 
Sodium (30)
5.23 ± 0.04*** 0.00 ± 0.00**** Nil 9.16 ± 0.04 17.61 ± 0.24** 32.35 ± 0.40****
BM (50) 2.4 ± 0.58 5.63 ± 0.49**** 7.66 ± 1.29 32.86 ± 1.93 43.56 ± 2.37***
N =6, ** p<0.01, *** p<0.01, **** p<0.001(compared to control)
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(P<0.01) delay in the onset of convulsion, 25.57±0.25 
minutes. It gave very good protection compared to the 
control (Table IV), whereas the diazepam-treated group 
had 0% mortality and no convulsions. BM significantly 
increased the onset time of the convulsion in this model. 
It is known that strychnine’s lethal convulsant action is a 
result of glycine antagonism in the spinal cord. Thus, the 
probable mechanism may be diazepam-like, displacing 
strychnine from the receptor site (Nogardy, 1998). Thus, 
BM may be clinically effective in simple partial seizures.
Effect on Hypoxia Stress-Induced Convulsion
Slow induction of hypoxic stress in mice resulted 
in increased respiratory rate, tremors and convulsions 
followed by death. Marked urination and defecation were 
also observed. Control animals developed convulsions 
within 46.25±0.14 min and died within 47.07± 0.02 
minutes. Diazepam at 4 mg/kg BW ip, halted the convul-
sions and significantly (P<0.01) prolonged the death time 
to 58.57±0.007 compared to controls. BM at a dose of 
55 mg/kg BW po, produced a significant delay in (P<0.01) 
the onset of convulsions, to 61.54±0.09 minutes, and an 
extended death time of 62.32 ±0.03 minutes (Table V). 
Pretreatment with adenosine 50 mg/kg BW ip produced 
latency of convulsions, 56.97±0.24 minutes, where this 
was statistically significant (P<0.02) compared to control. 
The difference in death time of control and adenosine 
group, 57.60±0.15 minutes, was also significant. Initial 
treatment with BM (55 mg/kg BW po), followed three 
hours and fifteen minutes later by adenosine, (50 mg/kg 
BW ip), caused a significant increase (P<0.001) in latency 
of convulsions, 66.44±0.52 minutes. Treatment of mice 
with theophylline (50 mg/kg bw ip) caused significantly 
earlier onset (P<0.01) of convulsions at 36.01±0.15 mi-
nutes, and death time at 36.94±0.23 minutes, compared to 
controls. After pretreatment with BM, (55 mg/kg bw ip) 
the decrease in the onset of convulsion and death time was 
reduced to 41.27±0.01 and 41.91±0.21 minutes, respec-
tively, compared to the control group, reaching statistical 
significance (P<0.02).
The physiological changes following acute hypoxia 
stress, such as convulsion and death, are mainly due to ce-
rebral hypoxia. BM showed a significant protective effect 
which appears to be centrally mediated. Whether the delay 
in the onset of convulsions was due to BM anticonvulsant 
properties or to inhibition of sympathetic discharge is 
unclear. (Kunchandy, Kulkarni, 1998).
Effect on Lithium Pilocarpine-Induced Status 
Epilepticus
Treatment with BM (50 mg/kg po) two hours 
before pilocarpine challenge produced a significant in-
crease (P<0.05) in the onset of convulsion, measured as 
29.33±2.45 minutes (Table VI).
The ability of BM at a dose of 50 mg/kg BW po to 
delay the onset of convulsion in this model, demonstrated 
its ability to counteract the underlying pathophysiology. 
The factors that influence the beginning and end 
point of status epilepticus are unknown but a role has 
been proposed for both glutamate mediated excitation and 
lack of GABA mediated inhibition (Vadillo, Noya, 1997). 
The seizure evolves from cholinergic hyperactivity to full 
blown clonic seizures occurring repeatedly. These seizures 
are aborted by diazepam and other diazepam-like drugs. 
TABLE IV – Strychnine-Induced convulsions in rats
Treatment 
(mg/Kg)
Onset of convulsions 
( Min ± SEM)
% Mortality
Control 1.66 ± 0.01 100
Diazepam(4) 0.0 ± 0.00*** Nil 0
BM (50) 25.57 ± 0.25*** 50
N = 6, *** p<0.01 (compared to control)
TABLE V - Hypoxic Stress-Induced convulsions in rats
Treatment (mg/kg) Onset of convulsion (Min ± SEM) Death Time ( Min ± SEM)
Control 46.25 ± 0.14 47.07 ±0.02
Diazepam 0.00 ± 0.00*** 58.57 ± 0.007***
BM(50) 61.54 ± 0.09*** 62.32 ± 0.03***
Adenosine (50) 56.97 ± 0.24** 57.60 ± 0.15***
Theophylline (50) 36.01± 0.15** 36.94 ± 0.23***
Adenosine (50) + BM (50) 66.44 ± 0.52**** 67.40 ± 0.52***
Theophylline (50) + BM (50) 41.27 ± 0.01** 41.31± 0.21**
N=6, ** p<0.01, *** p<0.01, **** p<0.001 (compared to control)
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Thus, BM may act based on the same mechanism as BDZ, 
i.e. through a GABAergic mechanism. This model may 
validate some aspects of psychomotor or temporal lobe 
epilepsy (Gupta et al., 1999).
CONCLUSION
The present study shows that the alcoholic extract 
of Bacopa monniera may function in a similar manner to 
BZD, given its benzodiazepine-like action, although the 
specific receptor interactions were not evaluated. Further 
evaluation of Bacopa monniera is needed to establish 
its exact mechanism of action. However, we conclude 
that the alcoholic extract of Bacopa monniera is a potent 
anticonvulsant drug.
ACKNOWLEDGEMENTS
The authors would like to thank the Principal of the 
KLE´s College of Pharmacy, Belgaum, for kindly provi-
ding the necessary facilities for this project.
REFERENCES
CHOPRA, R. N.; NAYAR, S. L.; CHOPRA, I. C. Glossary of 
Indian medicinal plants. New Delhi: CSIR, 1956. p.32.
CHAUDHRI, R. D. Herbal drug industry: a practical 
approach to industrial pharmacognosy. New Delhi: Eastern 
Publishers, 1985. 589 p.
GUPTA, Y. K.; MALHOTRA, J.; GEORGE, B.; KULKARNI, S. 
K. Methods and consideration for experimental evaluation 
of antiepileptic drugs. Indian J. Physiol. Pharmacol., v.43, 
n.1, p.25-43, 1999.
HANDA, S. S. Rasaayana drugs: part-II. Pharma Times, v.26, 
n.3, p.17-25, 1994.
TABLE VI - Lithium –Pilocarpine-Induced status epilepticus 
in rats
Treatment (mg/kg)
Onset of Convulsions 
(FC+ R) (Min ± SEM)
% Mortality
Control 
(Li + Pilocarpine)
21.33 ± 1.28 100
Diazepam (4) 90.5 ± 1.56** 0
BM (50) 29.33 ± 2.45* 83.33
N = 6, * p<0.05, ** p<0.02 (compared to control)
HANDA, S. S.; DEEPAK, M.; MANGAL, A. K. Indian herbal 
pharmacopoeia. Jammu: IDMA, Mumbai & RRL, 1998. 
v.1, p.30-37.
KRITIKAR, K. R.; BASU, B. D. Indian medicinal plants. 
Dehradun: Book Sellers & Publisher, 1999. v.3, p.1815-
1817.
KULKARNI, S. K. Handbook of experimental pharmacology. 
2.ed. Delhi: Vallabh Prakashan, 1993. p.43-45.
KULKARNI, S. K.; PASTY, J. Anticonvulsant profile of Siotone 
granules, a herbal preparation. Indian J. Expt. Biol., v.36, 
n.7, p.658-662, 1998.
K U L K A R N I ,  S .  K . ;  G E O R G E ,  B . ;  M AT H U R ,  R . 
Neuroprotection by Withania sommifera root extract against 
lithium pilocarpine induced seizures. Indian Drugs, v.35, 
n.4, p.208-216, 1998.
KUNCHANDY, J.; KULKARNI, S. K. Hypoxic stress induced 
convulsion and death: protective effect of α2-adrenoceptor 
and benzodiazepine receptor against Ro5-4864. Arch. Int. 
Pharacodyn., v.292, n.2, p.35-44, 1998.
MALHOTRA, C. L.; DAS, P. K. Pharmacological studies of 
Herpestis monniera Linn (Brahmi). Indian J. Med. Res., 
v.47, n.3, p.294-305, 1959.
NANDAVE, M.; OJHA, S. K.; JOSHI, S.; KUMARI, S.; ARYA, 
D. S. Cardioprotective effect Bacopa monneira against 
isoproterenol induced myocardial necrosis in rats. Int. J. 
Pharmacol., v.3, n.5, p.385-392, 2007.
NOGARDY, T. Medicinal chemistry-a biochemical approach. 
2.ed. Oxford: University Press, 1998. p.239-241.
RANA,  A .  C . ;  SANTANI ,  D .  D . ;  SALUJA,  A .  K . 
Pharmacological screening of the alcoholic extract of the 
leaves of Rubus ellipticus. Indian J. Pharm. Sci., v.52, n.4, 
p.174-177, 1990.
RAO, S. R.; AGARWAL, V. K. Effect of Bacopa monniera Linn 
on gastric ulceration and secretion. Indian J. Pharmacol., 
v.32, n.1, p.81, 2000.
RHO, J. M.; RAMAN, S. The pharmacologic basis of 
antiepileptic drug action. Epilepsia, v.40, n.1, p.1471-1483, 
1999.
Anticonvulsant activity of Bacopa monniera in rodents 649
SERTIA, J. A. A.; CAMARGO, E. A.; LUCIA, R. D.; 
PANIZZA, S. Pharmacology and toxicology of Centella 
asiatica extract. Fitoterapia, v.68, n.3, p.413-416, 1997.
SINGH, H. K.; DHAWAN, B. N. Neuropsycopharmacological 
effects of the ayurvedic nootropic Bacopa mooniera Linn. 
(Brahmi). Indian J. Pharmacol., v.29, n.5, p.359-365, 1997.
SUMATHI, T.; NONGBRI, A. Hepatoprotective effect of 
Bacoside-A, a major constituent of Bacopa mooniera Linn. 
Phytomedicine, v.15, n.10, p.901-905, 2008.
THE WEALTH OF INDIA. A Dictionary of Indian Raw 
Materials & Industrial Products: Raw materials. New Delhi: 
CSIR, 1985. v.IA(revised), p.2. 
VADILLO, F. J.; NOYA, M. Concept, classification and 
pathophysiology of status epilepticus Neuralgia, v.12, 
supl.6, p.2-9, 1997.
VIJI, V.; HELEN, A. Inhibition of lipoxygenases and 
cyclooxygenase-2 enzyme by extracts isolated from Bacopa 
monniera (L.) Wettst. J. Ethnopharmacol., v.118, n.2, 
p.305-311, 2008.
Received for publication on 11th April 2008.
Accepted for publication on 07th April 2009.

